Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.

Ullrich F, Bröckelmann PJ, Turki AT, Khan AM, Chiru ED, Vetter M, Tresckow BV, Wirth R, Cordoba R, Ortiz-Maldonado V, Fülöp T, Neuendorff NR.

Open source

DOI
10.1136/jitc-2024-009462
Published
2024-12-02
Container
J Immunother Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2024-009462,
  title = {Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.},
  author = {Ullrich F and  Bröckelmann PJ and  Turki AT and  Khan AM and  Chiru ED and  Vetter M and  Tresckow BV and  Wirth R and  Cordoba R and  Ortiz-Maldonado V and  Fülöp T and  Neuendorff NR.},
  year = {2024},
  journal = {J Immunother Cancer},
  doi = {10.1136/jitc-2024-009462},
  url = {https://doi.org/10.1136/jitc-2024-009462}
}

RIS

TY  - JOUR
TI  - Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.
AU  - Ullrich F
AU  -  Bröckelmann PJ
AU  -  Turki AT
AU  -  Khan AM
AU  -  Chiru ED
AU  -  Vetter M
AU  -  Tresckow BV
AU  -  Wirth R
AU  -  Cordoba R
AU  -  Ortiz-Maldonado V
AU  -  Fülöp T
AU  -  Neuendorff NR.
PY  - 2024
JO  - J Immunother Cancer
DO  - 10.1136/jitc-2024-009462
UR  - https://doi.org/10.1136/jitc-2024-009462
ER  - 

APA

F, U., PJ, B., AT, T., AM, K., ED, C., M, V., BV, T., R, W., R, C., V, O., T, F., & NR., N. (2024). Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma.. J Immunother Cancer. https://doi.org/10.1136/jitc-2024-009462

Source records